Higher Psoriasis Skin Clearance Is Associated with Lower Annual Indirect Costs in the United States: A Post Hoc Analysis from the CLEAR Study
Open Access
- 1 July 2018
- journal article
- research article
- Published by Academy of Managed Care Pharmacy in Journal of Managed Care & Specialty Pharmacy
- Vol. 24 (7) , 617-622
Abstract
BACKGROUND: Psoriasis is associated with a high economic burden to society. New psoriasis systemic treatments offer the potential for improved skin clearance. Whether a higher degree of clearing translates into economic benefit through decreased work impairment has not been fully determined. OBJECTIVE: To assess whether more complete clearing of psoriasis is associated with a reduction in disease-related indirect costs. METHODS: Pooled data from employed patients included in the CLEAR study, a phase 3b study comparing the efficacy and safety of secukinumab (337 subjects) versus ustekinumab (339 subjects), were classified into 4 levels of skin clearance improvement at weeks 16 and 52: Psoriasis Area and Severity Index (PASI) improvement from baseline of < 50% (PASI < 50), 50%-74% (PASI 50-74), 75%-89% (PASI 75-89), and ≥ 90% (PASI ≥ 90). Patients completed the Work Productivity and Activity Impairment questionnaire for psoriasis (WPAI-PSO), which assessed absenteeism, presenteeism, and a composite overall ...Keywords
This publication has 14 references indexed in Scilit:
- Economic Burden of Psoriasis and Potential Cost Offsets with Biologic Treatment: A Swedish Register AnalysisActa Dermato-Venereologica, 2016
- Health care resource use, productivity, and costs among patients with moderate to severe plaque psoriasis in the United StatesJournal of the American Academy of Dermatology, 2015
- Evaluating the economic burden of psoriasis in the United StatesJournal of the American Academy of Dermatology, 2015
- PASI90 response: the new standard in therapeutic efficacy for psoriasisJournal of the European Academy of Dermatology and Venereology, 2014
- Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis SurveyJournal of the American Academy of Dermatology, 2014
- Economic burden of comorbidities in patients with psoriasis is substantialJournal of the European Academy of Dermatology and Venereology, 2011
- The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: Results from NHANES 2003-2004Journal of the American Academy of Dermatology, 2009
- Association of patient-reported psoriasis severity with income and employmentJournal of the American Academy of Dermatology, 2007
- Psoriasis assessment tools in clinical trialsAnnals of the Rheumatic Diseases, 2005
- Severe Psoriasis – Oral Therapy with a New RetinoidDermatology, 1978